Login to Your Account

It’s ‘GAIM’ on for Neurophage with $17M series D

By Marie Powers
Staff Writer

Tuesday, March 25, 2014
Neurophage Pharmaceuticals Inc. moved one step closer to an investigational new drug filing and the initiation of human studies for lead candidate, NPT088, with the completion of a $17 million series D.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription